%0 Journal Article
%T Early and late outcomes of bevacizumab plus chemotherapy versus chemotherapy alone as a neoadjuvant treatment in HER2-negative nonmetastatic breast cancer: a meta-analysis of randomized controlled trials
%A Deyuan Fu
%A Jinli Wei
%A Yulin Luo
%J Archive of "OncoTargets and therapy".
%D 2018
%R 10.2147/OTT.S186816
%K bevacizumab
%K neoadjuvant chemotherapy
%K breast cancer
%K HER2-negative
%K randomized controlled trial
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296181/